Literature DB >> 2333543

Minimal change glomerulopathy in two patients after thymectomy.

P C Chan1, C C Lau, I K Cheng, K W Chan, B M Jones, M K Chan.   

Abstract

Two myasthenia gravis patients developed nephrotic syndrome due to minimal change glomerulopathy 3 to 14 years after thymectomy for malignant thymoma. Impaired cellular and humoral immunity has been documented in patients with thymoma and persists after thymectomy. The occurrence of minimal change disease lends support to the hypothesis that the glomerulopathy is secondary to T-cell dysfunction, resulting in production of a lymphokine which increases glomerular basement membrane permeability.

Entities:  

Mesh:

Year:  1990        PMID: 2333543

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy.

Authors:  Ramy M Hanna; Farid Arman; Umut Selamet; William D Wallace; Marina Barsoum; Anjay Rastogi; Niloofar Nobakht; Perry Shieh
Journal:  SAGE Open Med Case Rep       Date:  2019-08-08

2.  Nephrotic syndrome after thymectomy for myasthenia gravis.

Authors:  V B Kute; P R Shah; J D Shrimali; M R Gumber; H V Patel; A V Vanikar; H L Trivedi
Journal:  Indian J Nephrol       Date:  2013-01

Review 3.  Minimal change disease in a patient with myasthenia gravis: A case report.

Authors:  Jun-Li Tsai; Shang-Feng Tsai
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.